Liu Q - Search Results

1

A Novel IRAK4 Inhibitor DW18134 Ameliorates Peritonitis and Inflammatory Bowel Disease.

Huang Y, Ning Y, Chen Z, Song P, Tang H, Shi W, Wan Z, Huang G, Liu Q, Chen Y, Zhou Y, Li Y, Zhan Z, Ding J, Duan W, Xie H. Huang Y, et al. Among authors: liu q. Molecules. 2024 Apr 16;29(8):1803. doi: 10.3390/molecules29081803. Molecules. 2024. PMID: 38675622 Free PMC article.

2

From bench to bedside: current development and emerging trend of KRAS-targeted therapy.

Chen Y, Liu QP, Xie H, Ding J. Chen Y, et al. Acta Pharmacol Sin. 2024 Apr;45(4):686-703. doi: 10.1038/s41401-023-01194-4. Epub 2023 Dec 4. Acta Pharmacol Sin. 2024. PMID: 38049578 Review.

3

A novel strategy for treating oncogene-mutated tumors by targeting tumor microenvironment and synergistically enhancing anti-PD-1 immunotherapy.

Liu Y, Tong L, Zhang M, Zhang Q, Liu Q, Feng F, Li Y, Lai M, Tang H, Chen Y, Geng M, Duan W, Ding J, Xie H. Liu Y, et al. Among authors: liu q. Cancer Commun (Lond). 2024 Mar;44(3):438-442. doi: 10.1002/cac2.12521. Epub 2024 Feb 9. Cancer Commun (Lond). 2024. PMID: 38335159 Free PMC article. No abstract available.

4

Discovery of novel SOS1 inhibitors using machine learning.

Duo L, Chen Y, Liu Q, Ma Z, Farjudian A, Ho WY, Low SS, Ren J, Hirst JD, Xie H, Tang B. Duo L, et al. Among authors: liu q. RSC Med Chem. 2024 Mar 15;15(4):1392-1403. doi: 10.1039/d4md00063c. eCollection 2024 Apr 24. RSC Med Chem. 2024. PMID: 38665844 Free PMC article.

5

Almonertinib and alflutinib show novel inhibition on rare EGFR S768I mutant cells.

Wei X, Zhang G, Liu Q, Niu Z, Chu C, Liu C, Wang K, Li L, Wang R, Cui W, Xu H, Liu C, Wang Y, An L. Wei X, et al. Among authors: liu q. Clin Transl Oncol. 2024 May 30. doi: 10.1007/s12094-024-03494-5. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38814541

6

Economic evaluation of camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma in the United States and China.

Wei J, Xu K, Lin Y, Liu Q, Zhou C, Zhang P, Ma R, Zhang M, Zhang L, Li X. Wei J, et al. Among authors: liu q. Int J Clin Pharm. 2024 May 30. doi: 10.1007/s11096-024-01752-8. Online ahead of print. Int J Clin Pharm. 2024. PMID: 38814514

7

Unraveling the Structure-Activity-Stability Relationship over Gallium-Promoted HZSM-5 Nanocrystalline Aggregates for Propane Aromatization.

Wu Y, Lv Y, Wang R, Bao L, Zhang Z, Shi D, Zhang A, Zhang Y, Liu Q, Wu Q, Shi D, Chen K, Jiang G, Li H. Wu Y, et al. Among authors: liu q. Langmuir. 2024 May 30. doi: 10.1021/acs.langmuir.4c00544. Online ahead of print. Langmuir. 2024. PMID: 38814080

8

Does Social Support Moderate the Relationship between Frailty and Functional Ability Trajectory Among Community-Dwelling Older Adults?

Yu J, Si H, Liu Q, Li Y, Zhou W, Wang C. Yu J, et al. Among authors: liu q. J Gerontol A Biol Sci Med Sci. 2024 May 30:glae145. doi: 10.1093/gerona/glae145. Online ahead of print. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38813979

9

[Construction of a predictive model of death for sepsis-associated acute kidney injury].

Li X, Zhu C, Lan C, Liu Q. Li X, et al. Among authors: liu q. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024 Apr;36(4):381-386. doi: 10.3760/cma.j.cn121430-20240130-00098. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38813632 Chinese.

10

Effects of the interaction between cold spells and fine particulate matter on mortality risk in Xining: a case-crossover study at high altitude.

Ning Z, He S, Liu Q, Ma H, Ma C, Wu J, Ma Y, Zhang Y. Ning Z, et al. Among authors: liu q. Front Public Health. 2024 May 15;12:1414945. doi: 10.3389/fpubh.2024.1414945. eCollection 2024. Front Public Health. 2024. PMID: 38813422 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42,666 results

Search Page